AEterna Zentaris Inc (AEZS)
1.97
+0.02
(+0.77%)
USD |
NASDAQ |
Apr 23, 16:00
1.97
0.00 (0.00%)
After-Hours: 20:00
AEterna Zentaris Enterprise Value: -24.52M for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | -24.52M |
| April 19, 2024 | -24.55M |
| April 18, 2024 | -24.51M |
| April 17, 2024 | -24.40M |
| April 16, 2024 | -24.55M |
| April 15, 2024 | -24.50M |
| April 12, 2024 | -24.43M |
| April 11, 2024 | -23.96M |
| April 10, 2024 | -24.09M |
| April 09, 2024 | -23.92M |
| April 08, 2024 | -24.01M |
| April 05, 2024 | -24.21M |
| April 04, 2024 | -23.92M |
| April 03, 2024 | -23.82M |
| April 02, 2024 | -23.76M |
| April 01, 2024 | -23.87M |
| March 28, 2024 | -23.38M |
| March 27, 2024 | -23.92M |
| March 26, 2024 | -24.30M |
| March 25, 2024 | -24.35M |
| March 22, 2024 | -23.96M |
| March 21, 2024 | -24.45M |
| March 20, 2024 | -23.96M |
| March 19, 2024 | -23.77M |
| March 18, 2024 | -23.82M |
| Date | Value |
|---|---|
| March 15, 2024 | -23.48M |
| March 14, 2024 | -24.30M |
| March 13, 2024 | -24.09M |
| March 12, 2024 | -24.11M |
| March 11, 2024 | -24.89M |
| March 08, 2024 | -24.79M |
| March 07, 2024 | -25.03M |
| March 06, 2024 | -24.84M |
| March 05, 2024 | -24.79M |
| March 04, 2024 | -24.79M |
| March 01, 2024 | -24.79M |
| February 29, 2024 | -24.74M |
| February 28, 2024 | -24.94M |
| February 27, 2024 | -24.74M |
| February 26, 2024 | -24.55M |
| February 23, 2024 | -24.84M |
| February 22, 2024 | -25.59M |
| February 21, 2024 | -25.37M |
| February 20, 2024 | -25.50M |
| February 16, 2024 | -25.16M |
| February 15, 2024 | -24.98M |
| February 14, 2024 | -25.36M |
| February 13, 2024 | -25.03M |
| February 12, 2024 | -25.28M |
| February 09, 2024 | -25.32M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-42.72M
Minimum
Jun 15 2022
185.07M
Maximum
Feb 08 2021
-2.009M
Average
-0.0255M
Median
Enterprise Value Benchmarks
| Acasti Pharma Inc | 1.674M |
| Aurinia Pharmaceuticals Inc | 379.83M |
| Edesa Biotech Inc | 9.625M |
| Lexaria Bioscience Corp | 23.70M |
| Xenon Pharmaceuticals Inc | 2.380B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.635M |
| Revenue (Quarterly) | 0.121M |
| Total Expenses (Quarterly) | 6.517M |
| EPS Diluted (Quarterly) | -1.16 |
| Gross Profit Margin (Quarterly) | 54.55% |
| Profit Margin (Quarterly) | -4.66K% |
| Earnings Yield | -173.1% |
| Normalized Earnings Yield | -176.68 |